The Second-Generation XPO1 Inhibitor Eltanexor Inhibits Human Cytomegalovirus (HCMV) Replication and Promotes Type I Interferon Response

Overview of attention for article published in Frontiers in Microbiology, May 2021

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 5 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 24,755 followers.

靶点：XPO1 对应传染病病毒：人巨细胞病毒（HCMV）、呼吸道合胞病毒（RSV) 已有药物：Selinexor（塞利尼索）国内：德琪医药（开发和商业化） =》待验证链接： 1. https://t.co/X8G3uoYVTW 2. https://t.co/vBMPAuPRNC 3. https://t.co/f9I8p48wEs 4. https://t.co/Kc9NbcHlOp https://t.co/fde7tJSvjA

19 Feb 2022

Reply Repost Favourite

New Research: The Second-Generation XPO1 Inhibitor Eltanexor Inhibits Human Cytomegalovirus (HCMV) Replication and Promotes Type I Interferon Response https://t.co/Epj3qZQCd5 #microbiology

03 May 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.